Skip to content

Research on the establishment and standardization of reference systems for inspection items and drug testing using liquid chromatography-mass spectrometry technology

Research on the establishment and standardization of reference systems for inspection items and drug testing using liquid chromatography-mass spectrometry technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108463
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Noncommunicable Chronic Diseases

Interventions

Observation group:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Qualified specimens meeting the required study concentrations, such as residual serum with homocysteine levels within 7.1-11.0 mmol/L, and negative results for infectious markers including hepatitis B surface antigen (HBsAg), HIV antibody, syphilis antibody, and hepatitis C antibody (anti-HCV).

Exclusion criteria

Exclusion criteria: (1) The sample does not meet the requirements for sample collection and preservation; (2) It was found that the sample had been contaminated during the preservation process before the test operation; (3) Repeated sample enrollment; (4) The sample volume is insufficient to meet the detection requirements of the system to be evaluated and the comparative mass spectrometry method. (5) Other reasons that the researcher deems unsuitable for enrollment; (6) Any one of the above exclusion criteria can be met for exclusion.

Design outcomes

Primary

MeasureTime frame
Aldosterone;Homocysteine;Catecholamine hormones;Vitamin;Sarbanoid drugs;

Secondary

MeasureTime frame
Four items of blood transfusion;

Countries

China

Contacts

Public Contactwangjianbing

Guangdong Provincial Hospital of Chinese Medicine

wangjianbing625@163.com+86 135 3333 5712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026